Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore how diversified broad market strategies compare to target date funds for retirement. Learn key differences shaping risk, diversification, and long-term growth.
28,533 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Technology stocks lead a broad market rebound as June inflation data underscored cooling prices. Treasuries retreated...
Solana vaults higher as Bitcoin steadies near $65,000, sparking a broad green across the crypto market. SOL gains led...
Imagine a SpaceX-scale IPO changing how investors price AI startups. This article breaks down what spacex just bigges...
A year after XRP surged to $3.65, ripple (xrp) peaked $3.65 remains a milestone. Today, the token is far lower as reg...
OpenAI is nearing a private funding round that could push its valuation above $850 billion, a level that would outstr...
Dogecoin slides toward the $0.09 mark as on-chain activity shows holders scooping up DOGE while institutional flows s...
Planet Labs delivered its first full year of profitability, with a ballooning backlog and AI partnerships driving a r...
Bitcoin slipped below a key resistance area, opening a test of a critical support confluence around $70k-$72k. Analys...
YieldMax MSTY delivered large payouts this quarter even as its share price fell, spotlighting the potential for retur...
Toll Brothers posted a strong first quarter, underscoring resilience in the luxury segment through disciplined execut...
A disappointing earnings quarter sent stubhub stock just crashed. This guide breaks down the reasons, what it signals...